Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | GoHealth, Inc. GOCO |
T. Rowe Price Associates, Inc. | 14,193 0.100% |
-369,174![]() (-96.30%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
T. Rowe Price Associates, Inc. | 3,550,528 6.900% |
3,550,528![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Opendoor Technologies Inc. OPEN |
T. Rowe Price Associates, Inc. | 36,169,638 5.900% |
36,169,638![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | PROG Holdings, Inc. PRG |
T. Rowe Price Associates, Inc. | 5,578,830 8.500% |
-332,004![]() (-5.62%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Imago BioSciences, Inc. IMGO |
T. Rowe Price Associates, Inc. | 2,241,917 6.600% |
2,241,917![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | FIGS, Inc. FIGS |
T. Rowe Price Associates, Inc. | 14,057,521 9.200% |
14,057,521![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Asana, Inc. ASAN |
T. Rowe Price Associates, Inc. | 35,270 0.000% |
-4,511,852![]() (-99.22%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Tenaya Therapeutics, Inc. TNYA |
T. Rowe Price Associates, Inc. | 2,993,503 7.200% |
2,993,503![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Eucrates Biomedical Acquisition Corp. EUCRU |
T. Rowe Price Associates, Inc. | 730,864 5.400% |
730,864![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Immuneering Corporation IMRX |
T. Rowe Price Associates, Inc. | 3,188,505 12.200% |
151,523![]() (+4.99%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Rapid Micro Biosystems, Inc. RPID |
T. Rowe Price Associates, Inc. | 2,199,746 6.300% |
2,199,746![]() (New Position) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Equitable Holdings, Inc. EQH |
T. Rowe Price Associates, Inc. | 45,033,655 11.100% |
-11,167,346![]() (-19.87%) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | U.S. Xpress Enterprises, Inc. USX |
T. Rowe Price Associates, Inc. | 1,680,305 4.800% |
-409,799![]() (-19.61%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Replimune Group, Inc. REPL |
T. Rowe Price Associates, Inc. | 5,868,638 12.500% |
799,188![]() (+15.76%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Endava plc DAVA |
T. Rowe Price Associates, Inc. | 4,210,823 10.900% |
365,574![]() (+9.51%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | IGM Biosciences, Inc. IGMS |
T. Rowe Price Associates, Inc. | 2,371,275 9.100% |
1,042,491![]() (+78.45%) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | The Pennant Group, Inc. PNTG |
T. Rowe Price Associates, Inc. | 4,069,175 14.200% |
-193,174![]() (-4.53%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | The Baldwin Insurance Group, Inc. BWIN |
T. Rowe Price Associates, Inc. | 4,820,435 8.400% |
2,409,858![]() (+99.97%) |
Filing History |
2022-02-14 2:34 pm Sale |
2021-12-31 | 13G | Match Group, Inc. MTCH |
T. Rowe Price Associates, Inc. | 14,172,214 5.000% |
-7,254,234![]() (-33.86%) |
Filing History |
2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Annexon, Inc. ANNX |
T. Rowe Price Associates, Inc. | 2,876,667 7.400% |
2,876,667![]() (New Position) |
Filing History |